DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

Hyderabad: Telangana Drugs Control Administration (DCA) busted two pharmacies operating without drug licenses.

In the first incident, DCA conducted a raid on Sri Sai Super Speciality Dental Hospital in Wanaparthy which was operating a pharmacy without a drug license, and seized a significant quantity of drugs worth Rs. 80,000 intended for sale.

M Venkata Suresh, a dentist, has been operating the pharmacy in the hospital without a drug license. During the raid, officers detected an unauthorized stocking of medicines intended for sale. 24 varieties of medicines, including antibiotics, painkiller drugs, and other dental medications, were found stocked at the premises. DCA officials seized the entire stock, worth Rs. 80,000, during the raid.

DCA officers lifted samples for analysis. Further investigation will be conducted, and appropriate action will be taken by the law against offenders.

In a separate incident, DCA raided a medical shop at Noor Khan Bazar, Charminar, Hyderabad, which was being operated without a drug license. During the raid, authorities seized 36 types of medicines, including antibiotics, habit-forming drugs such as Alprazolam tablets and Codeine syrups.

Mir Hussain Hyder Razvi was found illegally operating ‘NAJM Pharmacy’ at the premises without a valid drug license.

DCA officers discovered the unauthorized stocks of medicines. Thirty-six types of medicines including habit-forming drugs, antibiotics, anti-ulcer drugs, cough syrups, and others, were found stocked for sale at the premises. Habit-forming drugs such as Alprazolam Tablets and Codeine Syrups, were also found at the unlicensed premises.

In another incident, Drugs Control Administration officials seized ‘Tenebetic-20 tablets’ (Teneligliptin tablets IP 20 mg) at Kothapet Village, Uppal Mandal.

Teneligliptin tablets 20 mg sold under the brand name ‘Tenebetic-20 tablets’ are under price control as per the Drugs (Prices Control) Order, 2013. The price of the product shall be fixed by the National Pharmaceutical Pricing Authority (NPPA), Government of India.

The product ‘Tenebetic-20 tablets’ (Teneligliptin tablets IP 20 mg) of Batch No. IS23068, Mfg. date: 04-2023, Exp. Date: 03-2025, Manufactured by: Ind-Swift Limited, Industrial Growth Centre, Phase-1, Samba-184121, Jammu and Kashmir, Marketed by: Elder Project Limited, 302, 3rd Floor, Plot no. 174, Kunthu Commerce Centre, Near Ayyappa Temple, Bangur Nagar, Goregaon West, Mumbai-400104, bears MRP as Rs. 151.25 per 10 Tablets on the label of the product which is a violation of Drugs (Prices Control) Order, 2013.

The Ceiling price fixed by the Central Government including Wholesale Price Index for the product “Teneligliptin Tablets 20 mg” is Rs 11.08 per tablet i.e. Rs. 110.8 per 10 tablets (Ceiling Price).

Hence Maximum Retail Price (MRP) i.e. including GST 12 % should not be more than Rs. 124.1 per strip of 10 tablets (MRP=Ceiling Price+GST) The firm overpriced the product. The firm charged an excess of Rs. 27.20/- per strip of 10 tablets, which is a violation of the Drugs (Prices Control) Order, 2013.

Related Posts

Puresta launches EVERQ, AI-powered skin-health platform

Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.…

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre

US FDA launches expedited IND Pilot, begins accepting applications

US FDA launches expedited IND Pilot, begins accepting applications

PIL in SC seeks time-bound probe, stringent action against fake drug networks

PIL in SC seeks time-bound probe, stringent action against fake drug networks

Ghaziabad: Fake supplement racket busted, 5 held

Ghaziabad: Fake supplement racket busted, 5 held

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records